These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

420 related articles for article (PubMed ID: 31139075)

  • 1. NMDA Receptor Antagonist Effects on Speech-Related Mismatch Negativity and Its Underlying Oscillatory and Source Activity in Healthy Humans.
    de la Salle S; Shah D; Choueiry J; Bowers H; McIntosh J; Ilivitsky V; Knott V
    Front Pharmacol; 2019; 10():455. PubMed ID: 31139075
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rodent Mismatch Negativity/theta Neuro-Oscillatory Response as a Translational Neurophysiological Biomarker for N-Methyl-D-Aspartate Receptor-Based New Treatment Development in Schizophrenia.
    Lee M; Balla A; Sershen H; Sehatpour P; Lakatos P; Javitt DC
    Neuropsychopharmacology; 2018 Feb; 43(3):571-582. PubMed ID: 28816240
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of cerebral type 1 cannabinoid receptors is associated with impaired auditory mismatch negativity generation in the ketamine model of schizophrenia.
    Roser P; Haussleiter IS; Chong HJ; Maier C; Kawohl W; Norra C; Juckel G
    Psychopharmacology (Berl); 2011 Dec; 218(4):611-20. PubMed ID: 21590281
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interactive effects of an N-methyl-d-aspartate receptor antagonist and a nicotinic acetylcholine receptor agonist on mismatch negativity: Implications for schizophrenia.
    Hamilton HK; D'Souza DC; Ford JM; Roach BJ; Kort NS; Ahn KH; Bhakta S; Ranganathan M; Mathalon DH
    Schizophr Res; 2018 Jan; 191():87-94. PubMed ID: 28711472
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mismatch Negativity and Theta Oscillations Evoked by Auditory Deviance in Early Schizophrenia.
    Hua JPY; Roach BJ; Ford JM; Mathalon DH
    Biol Psychiatry Cogn Neurosci Neuroimaging; 2023 Dec; 8(12):1186-1196. PubMed ID: 36931469
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effects of ketamine on the mismatch negativity (MMN) in humans - A meta-analysis.
    Rosburg T; Kreitschmann-Andermahr I
    Clin Neurophysiol; 2016 Feb; 127(2):1387-1394. PubMed ID: 26699665
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ketamine-induced deficits in auditory and visual context-dependent processing in healthy volunteers: implications for models of cognitive deficits in schizophrenia.
    Umbricht D; Schmid L; Koller R; Vollenweider FX; Hell D; Javitt DC
    Arch Gen Psychiatry; 2000 Dec; 57(12):1139-47. PubMed ID: 11115327
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Glutamatergic deficit and schizophrenia-like negative symptoms: new evidence from ketamine-induced mismatch negativity alterations in healthy male humans.
    Thiebes S; Leicht G; Curic S; Steinmann S; Polomac N; Andreou C; Eichler I; Eichler L; Zöllner C; Gallinat J; Hanganu-Opatz I; Mulert C
    J Psychiatry Neurosci; 2017 Jun; 42(4):273-283. PubMed ID: 28556775
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mismatch negativity predicts psychotic experiences induced by NMDA receptor antagonist in healthy volunteers.
    Umbricht D; Koller R; Vollenweider FX; Schmid L
    Biol Psychiatry; 2002 Mar; 51(5):400-6. PubMed ID: 11904134
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of nicotine on the neurophysiological and behavioral effects of ketamine in humans.
    Mathalon DH; Ahn KH; Perry EB; Cho HS; Roach BJ; Blais RK; Bhakta S; Ranganathan M; Ford JM; D'Souza DC
    Front Psychiatry; 2014; 5():3. PubMed ID: 24478731
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Auditory discrimination profiles of speech sound changes in 6-year-old children as determined with the multi-feature MMN paradigm.
    Lovio R; Pakarinen S; Huotilainen M; Alku P; Silvennoinen S; Näätänen R; Kujala T
    Clin Neurophysiol; 2009 May; 120(5):916-21. PubMed ID: 19386542
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Spectral and phase-coherence correlates of impaired auditory mismatch negativity (MMN) in schizophrenia: A MEG study.
    Sauer A; Grent-'t-Jong T; Zeev-Wolf M; Singer W; Goldstein A; Uhlhaas PJ
    Schizophr Res; 2023 Nov; 261():60-71. PubMed ID: 37708723
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Auditory Mismatch Negativity and P300a Elicited by the "Optimal" Multi-feature Paradigm in Early Schizophrenia.
    Fisher DJ; Campbell DJ; Abriel SC; Ells EML; Rudolph ED; Tibbo PG
    Clin EEG Neurosci; 2018 Jul; 49(4):238-247. PubMed ID: 29502452
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differential of Frequency and Duration Mismatch Negativity and Theta Power Deficits in First-Episode and Chronic Schizophrenia.
    Xiong YB; Bo QJ; Wang CM; Tian Q; Liu Y; Wang CY
    Front Behav Neurosci; 2019; 13():37. PubMed ID: 30894804
    [No Abstract]   [Full Text] [Related]  

  • 15. Mismatch negativity generation in the human 5HT2A agonist and NMDA antagonist model of psychosis.
    Heekeren K; Daumann J; Neukirch A; Stock C; Kawohl W; Norra C; Waberski TD; Gouzoulis-Mayfrank E
    Psychopharmacology (Berl); 2008 Jul; 199(1):77-88. PubMed ID: 18488201
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Atypical central auditory speech-sound discrimination in children who stutter as indexed by the mismatch negativity.
    Jansson-Verkasalo E; Eggers K; Järvenpää A; Suominen K; Van den Bergh B; De Nil L; Kujala T
    J Fluency Disord; 2014 Sep; 41():1-11. PubMed ID: 25066139
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of recurrent acute otitis media on cortical speech-sound processing in 2-year old children.
    Haapala S; Niemitalo-Haapola E; Raappana A; Kujala T; Suominen K; Kujala T; Jansson-Verkasalo E
    Ear Hear; 2014; 35(3):e75-83. PubMed ID: 24370565
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reduction of phonetic mismatch negativity may depict illness course and predict functional outcomes in schizophrenia.
    Mi L; Wang L; Li X; She S; Li H; Huang H; Zhang J; Liu Y; Zhao J; Ning Y; Zheng Y
    J Psychiatr Res; 2021 May; 137():290-297. PubMed ID: 33735719
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mismatch negativity as a biomarker of theta band oscillatory dysfunction in schizophrenia.
    Javitt DC; Lee M; Kantrowitz JT; Martinez A
    Schizophr Res; 2018 Jan; 191():51-60. PubMed ID: 28666633
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The right profile: mismatch negativity in schizophrenia with and without auditory hallucinations as measured by a multi-feature paradigm.
    Fisher DJ; Labelle A; Knott VJ
    Clin Neurophysiol; 2008 Apr; 119(4):909-21. PubMed ID: 18261954
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.